Functional gastrointestinal disorders(FGIDs), Esophageal motility disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients scheduled endoscopy in our hospital for symptoms of suspected FGIDs. 2.Patients with no abnormalities at esophagogastroduodenography(EGD) in this study. 3.Patients who can understand the explanation of this research plan and can give their own consent. 4.Patients who are 20 years old or older at the time of obtaining consent.
Exclusion criteria
Exclusion criteria: 1.Pregnant women or patients who may be pregnant. 2.Patients with a history of gastrointestinal surgery(excluding endoscopic procedures). 3.Patients requiring the use of spasmolytic drug ( butylscopolamine, glucagon) during endoscopy. 4.Patients in poor general condition due to severe cardiopulmonary impairment. 5.Patients who are unable to understand examination procedures or express symptoms due to mental illness or cognitive dysfunction. 6.Patients who are judged inappropriate by physician participating in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of gastric distensibility evaluated by intragastric pressure and CO2 injection volume and symptom scale in patients with functional dyspepsia and controls | — |
Secondary
| Measure | Time frame |
|---|---|
| -A study of gastric distensibility and lower esophageal sphincter function evaluated by intragastric pressure and CO2 injection volume in patients with gastroesophageal reflux disease(GERD). -A study of gastric distensibility and lower esophageal sphincter function evaluated by intragastric pressure and CO2 injection volume in patients with functional heartburn. -A study of esophageal distensibility evaluated by intra-esophageal pressure and CO2 injection volume in patients with esophageal motility disorders. -A comparative study of gastric distensibility and contrast-enhanced gastric capacity in patients with functional dyspepsia and controls. -A study of Evaluation for gastrointestinal hypersensitivity using intra-gastrointestinal pressure, CO2 injection volume, and BIS(Bispectral Index). | — |
Countries
Japan
Contacts
Graduate School of Medicine, Kyushu University Department of Medicine and Bioregulatory Science